FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096082 [Registered on: 15/10/2025] Trial Registered Prospectively
Last Modified On: 15/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Process of Care Changes 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of Palasha Kshara and udumbaradi taila pichu in the treatment of cervical erosion. 
Scientific Title of Study   A Randomised Comparative Control Clinical Study of Palasha Kshara and Udumbaradi Taila Pichu in the management of Cervical Erosion. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Manju Chouksey 
Designation  PhD Scholar 
Affiliation  Institute of Ayurvedic Studies and Research, Shri Krishna AYUSH Univercity, Kurukshetra, Haryana 
Address  Institute of Ayurvedic Studies and Research, Shri Krishna AYUSH Univercity, Umri Road, Sector-8, Kurukshetra, Haryana, 136118

Kurukshetra
HARYANA
136118
India 
Phone  9887913372  
Fax    
Email  manjuchoksey23@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jitesh Kumar Panda 
Designation  Chairmen, Professor and Head 
Affiliation  Institute of Ayurvedic Studies and Research, Shri Krishna AYUSH Univercity, Kurukshetra, Haryana 
Address  Institute of Ayurvedic Studies and Research, Shri Krishna AYUSH Univercity, Umri Road, Sector-8, Kurukshetra, Haryana, 136118

Kurukshetra
HARYANA
136118
India 
Phone  9896033056  
Fax    
Email  drjk67@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sidheswar Sathua 
Designation  Professor and Head 
Affiliation  Govt. Dhanwantari Ayurvedic Medical College and Hospital Ujjain Madhya Pradesh  
Address  Govt. Dhanwantari Ayurvedic Medical College and Hospital Ujjain Madhya Pradesh 456001

Ujjain
MADHYA PRADESH
456001
India 
Phone  8319917193  
Fax    
Email  ssathua8@gmail.com  
 
Source of Monetary or Material Support  
Govt. Dhanwantari Ayurvedic Medical College and Hospital Mangalnath Road Ujjain Madhya Pradesh India 456001  
 
Primary Sponsor  
Name  Dr Manju Chouksey 
Address  Govt Dhanwantari Ayurvedic Medical College and Hospital Mangalnath Road ujjain Madhya Pradesh 456001 
Type of Sponsor  Other [Assitant Professor in Govt. Dhanwantari Ayurvedic Medical College and Hospital M. P. ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Manju Chouksey  Govt. Dhanwantari Ayurvedic Medical College and Hospital Ujjain Madhya Pradesh  Govt. Dhanwantari Ayurvedic Medical College and Hospital Prasuti and Striroga OPD no 45 Chimanganjmandi Ujjain Madhya Pradesh 456006
Ujjain
MADHYA PRADESH 
9887913372

manjuchoksey23@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE SHRI KRISHNA AYUSH University Kurukshetra Haryana  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N86||Erosion and ectropion of cervix uteri. Ayurveda Condition: KARNINI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Palasha Kshara, Reference: Sushrut Sutra Sthana-11, Route: Topical, Dosage Form: Kshara , Dose: 2(g), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 7 Days, Reference: No, Route: NA, Dosage Form: Kshara , Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(3) Medicine Name: Dhatakyadi Taila Pichu, Reference: Charak Chikitsa Sthana-30, Route: Topical, Dosage Form: Taila, Dose: 5(ml), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(4) Medicine Name: 14 Days, Reference: No, Route: NA, Dosage Form: Taila, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
2Intervention ArmDrugClassical(1) Medicine Name: Palasha Kshara, Reference: Sushrut Sutra Sthana-11, Route: Topical, Dosage Form: Kshara , Dose: 2(g), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 7 Days, Reference: No, Route: NA, Dosage Form: Kshara , Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(3) Medicine Name: Udumbaradi Taila Pichu, Reference: Charak Chikitsa Sthana-30, Route: Topical, Dosage Form: Taila, Dose: 5(ml), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(4) Medicine Name: 14 Days, Reference: No, Route: NA, Dosage Form: Taila, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Married patients of age between 21 to 45 years with clinical signs and symptoms of Cervical Erosion and 50% of erosion which will diagnose by the per speculum examination will be registered for the present clinical trial. 
 
ExclusionCriteria 
Details  Patient not fulfilling inclusion criteria, Patient having any anatomical disorder, abnormal discharge due to malignancy, Patient having systemic disease such as diabetes mellitus, HIV, VDRL positive patients. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Patient will get rid from the disease ( Cervical Erosion)  2 months 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="124"
Sample Size from India="62" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   22/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

It is control clinical trial in which 124 patients will be selected on the basis of inclusion and exclusion criteria. Each group contains 62 patients. Cervical Erosion will be assessed daily during application and then after a month for 2 consecutive menstrual cycle. Clinical assessment will be done after completion of 2 consecutive menstrual cycles. The treatment planned on 2nd or 3rd day after bleeding phase of menstrual cycle.is over. In Group A that is trial group Palasha Kshar will apply for 7 sitting on alternate day and Udumbaradi Taila Pichu for 14 days daily. In Group B that is Control group Palasha Kshar will apply for 7 sitting on alternate day and Dhatakyadi taila Pichu for 14 days daily.

 
Close